Institute of Hepatobiliary Surgery, Fuzhou General Hospital, Fuzhou 350025, China.
Hepatobiliary Pancreat Dis Int. 2009 Oct;8(5):479-82.
Fulminant hepatic failure manifests a rapid onset, serious complications, and a high mortality, but still there is a possibility of recovery. Once the patient is able to pass a crisis, the liver is able to regenerate completely and regain its normal function. Therefore it is of vital importance to determine the eligible timing for transplantation. Premature surgery might result in a loss of the chance of internal medical treatment and misuse of liver resources, whereas delayed surgery might increase the difficulty of treatment in the preoperative period and the possibility of complications and medical expense, which eventually result in decreased rate of success and survival. This problem remains worldwide how to choose the optional timing of operation.
Thirty-six patients with severe hepatitis were treated by orthotopic liver transplantation. The distribution of MELD scores in these patients was: 10-19 in 8 patients, 20-29 in 10, 30-39 in 11, and 40 in 7. They were divided into two groups: MELD score <30 and MELD score >or=30. Parameters (1-year survival rate, complications, preoperative use of artificial liver, operative time, volume of bleeding and blood transfusion, and average hospital costs) were examined as prognostic factors after liver transplantation.
The 1-year survival rate of the MELD score <30 group was higher than that of the >or=30 group (77.8% and 33.3%, P=0.007), and the rate of complications in the <30 group was lower (P=0.012). There were no differences in the timing of artificial liver treatment, operative time, operative hemorrhage, and transfusion between the two groups (P=0.742). But the average daily hospital cost in the MELD score >or=30 group was higher (P=0.008).
This study shows that when the MELD score is <30 it may be the optimal time to perform liver transplantation for patients with severe hepatitis.
暴发性肝衰竭起病急骤,并发症严重,死亡率高,但仍有完全恢复的可能。一旦患者能够度过危机,肝脏就能够完全再生并恢复正常功能。因此,确定合适的移植时机至关重要。手术过早可能导致错失内外科治疗机会和肝脏资源的滥用,而手术过晚则会增加术前治疗难度和并发症及医疗费用的可能性,最终导致成功率和存活率降低。这个问题在全球范围内仍然存在,即如何选择手术的可选时机。
对 36 例重型肝炎患者进行原位肝移植治疗。这些患者的 MELD 评分分布如下:8 例患者的 MELD 评分为 10-19,10 例患者的 MELD 评分为 20-29,11 例患者的 MELD 评分为 30-39,7 例患者的 MELD 评分为 40。他们被分为两组:MELD 评分<30 和 MELD 评分≥30。检查了术后参数(1 年生存率、并发症、术前使用人工肝、手术时间、出血量和输血量以及平均住院费用)作为肝移植后的预后因素。
MELD 评分<30 组的 1 年生存率高于 MELD 评分≥30 组(77.8%和 33.3%,P=0.007),并发症发生率较低(P=0.012)。两组间人工肝治疗时机、手术时间、手术出血量和输血量无差异(P=0.742)。但 MELD 评分≥30 组的平均日住院费用较高(P=0.008)。
本研究表明,当 MELD 评分<30 时,可能是重型肝炎患者进行肝移植的最佳时机。